SCOPUS 정보 검색 플랫폼

Annals of Pharmacotherapy

Volumn 35, Issue 10, 2001, Pages 1270-1273

Treatment of bulimia nervosa with ondansetron

(2) Fung, S M a Ferrill, M J a

a PROTEIN DESIGN LABS INC (United States)

Author keywords

Bulimia nervosa; Ondansetron

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; ONDANSETRON; SEROTONIN ANTAGONIST;

BEHAVIOR THERAPY; BINGE EATING DISORDER; BULIMIA; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL INFORMATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0034797017 PISSN: 10600280 EISSN: None Source Type: Journal
DOI: 10.1345/aph.10400 Document Type: Review

Times cited : (7)

References (14)

1
- 84870465485
- Washington, DC: American Psychiatric Association
- (1994) Diagnostic and statistical manual of mental disorders, 4th ed.

2
- 0029846997
- Epidemiology of the eating disorders
- (1996) Psychiatr Clin North Am , vol.19 , pp. 681-700
- Hsu, L.K.¹

3
- 0033535479
- Eating disorders
- (1999) N Engl J Med , vol.340 , pp. 1092-1098
- Becker, A.E.¹ Grinspoon, S.K.² Klibanski, A.³ Herzog, D.B.⁴

4
- 0032577351
- Eating disorders: Progress and problems
- (1998) Science , vol.280 , pp. 1387-1390
- Walsh, B.T.¹ Devlin, M.J.²

5
- 0031035074
- Outcome in bulimia nervosa
- (1997) Am J Psychiatry , vol.154 , pp. 313-321
- Keel, P.K.¹ Mitchell, J.E.²

6
- 85037400163
- Research Triangle Park, NC: Glaxo Wellcome Inc., June
- (2000) Package insert. Zofran (ondansetron)

7
- 0026439365
- Nociceptive, but not tactile, thresholds are elevated in bulimia nervosa
- (1992) Biol Psychiatry , vol.32 , pp. 462-466
- Faris, P.L.¹ Raymond, N.C.² De Zwaan, M.³ Howard, L.A.⁴ Eckert, E.D.⁵ Mitchell, J.E.⁶

8
- 18844474370
- 3 receptor, on the dynamic association between bulimic behaviors and pain thresholds
- (1998) Pain , vol.77 , pp. 297-303
- Faris, P.L.¹ Kim, S.W.² Meller, W.H.³ Goodale, R.L.⁴ Hofbauer, R.D.⁵ Oakman, S.A.⁶

9
- 0034222941
- 3 antagonist therapy of bulimia nervosa: A peripherally active agent for a central nervous system eating disorder
- (2000) Gastroenterology , vol.119 , pp. 271-272
- Faris, P.L.¹ Kim, S.W.² Meller, W.H.³ Goodale, R.L.⁴ Oakman, S.A.⁵ Marshall, A.M.⁶

10
- 0031434719
- Treatment of bulimia nervosa with ondansetron
- (1997) Arch Gen Psychiatry , vol.54 , pp. 969-970
- Hartman, B.K.¹ Faris, P.L.² Kim, S.W.³ Raymond, N.C.⁴ Goodale, R.L.⁵ Meller, W.H.⁶

11
- 0034603587
- Effect of decreasing vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial
- (2000) Lancet , vol.355 , pp. 792-797
- Faris, P.L.¹ Kim, S.W.² Meller, W.H.³ Goodale, R.L.⁴ Oakman, S.A.⁵ Hofbauer, R.D.⁶

12
- 0034603342
- Treatment of chronic bulimic symptoms: New answers, more questions
- (2000) Lancet , vol.355 , pp. 769-770
- Kiss, A.¹

13
- 0029060724
- Dysphoria after treatment with ondansetron
- (1995) Am J Psychiatry , vol.152 , pp. 1101
- Oren, D.A.¹

14
- 0034222941
- 5-HT3 antagonist therapy of bulimia nervosa: A peripherally active agent for a central nervous system eating disorder
- (2000) Gastroenterology , vol.119 , pp. 271-272
- Hasler, W.L.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.